6 May 2025 PAGB invited to speak on Deloitte panel Last week, we were pleased to be invited to participate in Deloitte's panel on 'Powering the consumer health revolution'. PAGB invited to speak on Deloitte panel
16 April 2025 DMCCA grants new powers to CMA and expands list of banned practices As of 6 April, key parts the DMCCA have come into force, including expanded powers for the Competition and Markets Authority (CMA) and updates to Unfair Commercial Practices. DMCCA grants new powers to CMA and expands list of banned practices
7 April 2025 Michelle Riddalls is latest guest on Over The Counter podcast with HBW Insights Across two episodes, Michelle joins HBW Insight's David Ridley to chat about PAGB's strategy and ongoing work. Michelle Riddalls is latest guest on Over The Counter podcast with HBW Insights
3 April 2025 PAGB updates summary of MHRA’s post-Brexit guidance for medicines This week, we released our updated summary of MHRA’s regulatory guidance for medicines. This substantial update follows the numerous changes to guidance since implementation of the Windsor Framework in January 2025. PAGB updates summary of MHRA’s post-Brexit guidance for medicines
6 May 2025 PAGB invited to speak on Deloitte panel Last week, we were pleased to be invited to participate in Deloitte's panel on 'Powering the consumer health revolution'. PAGB invited to speak on Deloitte panel
16 April 2025 DMCCA grants new powers to CMA and expands list of banned practices As of 6 April, key parts the DMCCA have come into force, including expanded powers for the Competition and Markets Authority (CMA) and updates to Unfair Commercial Practices. DMCCA grants new powers to CMA and expands list of banned practices
7 April 2025 Michelle Riddalls is latest guest on Over The Counter podcast with HBW Insights Across two episodes, Michelle joins HBW Insight's David Ridley to chat about PAGB's strategy and ongoing work. Michelle Riddalls is latest guest on Over The Counter podcast with HBW Insights
3 April 2025 PAGB updates summary of MHRA’s post-Brexit guidance for medicines This week, we released our updated summary of MHRA’s regulatory guidance for medicines. This substantial update follows the numerous changes to guidance since implementation of the Windsor Framework in January 2025. PAGB updates summary of MHRA’s post-Brexit guidance for medicines
